SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D - General Statement of Acquisition of Beneficial Ownership:
SEC Accession No. 0000919574-11-004954
Filing Date
2011-08-16
Accepted
2011-08-16 17:01:38
Documents
1

Document Format Files

Seq Description Document Type Size
1 d1218985_13d.htm SC 13D 202982
  Complete submission text file 0000919574-11-004954.txt   204770
Mailing Address 12276 WILKINS AVENUE ROCKVILLE MD 20852
Business Address 12276 WILKINS AVENUE ROCKVILLE MD 20852 301-770-3099
NABI BIOPHARMACEUTICALS (Subject) CIK: 0000072444 (see all company filings)

IRS No.: 591212264 | State of Incorp.: DE | Fiscal Year End: 1226
Type: SC 13D | Act: 34 | File No.: 005-31596 | Film No.: 111040629
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address 595 MADISON AVENUE 17TH FLOOR NEW YORK NY 10022
Business Address 595 MADISON AVENUE 17TH FLOOR NEW YORK NY 10022 212-554-2390
683 Capital Management, LLC (Filed by) CIK: 0001404574 (see all company filings)

IRS No.: 205100992 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D